13F HOLDINGS REPORT
Aisling Capital Management LP
Quarter ended Q4 2025 · Filed February 10, 2026 · Accession 0001766721-26-000001
Total Value
$478.9M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BridgeBio Pharma Inc. (BBIO) | BBIO | 5,089,611 | $389.3M | 81.29% |
| 2 | Syndax Pharmaceuticals, Inc. (SNDX) | SNDX | 1,316,806 | $27.7M | 5.78% |
| 3 | Monte Rosa Therapeutics Inc (GLUE) | GLUE | 1,472,331 | $23.1M | 4.82% |
| 4 | Bicara Therapeutics Inc. (BCAX) | BCAX | 568,919 | $9.6M | 2.00% |
| 5 | Compass Pathways Plc (CMPS) | CMPS | 1,198,418 | $8.3M | 1.73% |
| 6 | BridgeBio Oncology Therapeutics (BBOT) | BBOT | 564,625 | $7.1M | 1.48% |
| 7 | CalciMedica, Inc. (CALC) | CALC | 521,114 | $3.4M | 0.72% |
| 8 | Scholar Rock Holding Corporation (SRRK) | SRRK | 77,031 | $3.4M | 0.71% |
| 9 | Biomea Fusion Inc (BMEA) | BMEA | 2,048,757 | $2.5M | 0.53% |
| 10 | Urogen Pharma Ltd. (URGN) | URGN | 108,000 | $2.5M | 0.53% |
| 11 | Aclaris Therapeutics Inc (ACRS) | ACRS | 434,455 | $1.3M | 0.27% |
| 12 | Marker Therapeutics, Inc. (MRKR) | MRKR | 325,370 | $484,801 | 0.10% |
| 13 | OnKure Therapeutics, Inc. (OKUR) | OKUR | 88,607 | $256,960 | 0.05% |